Quest Diagnostics (DGX) Change in Accured Expenses (2009 - 2026)

Quest Diagnostics has disclosed Change in Accured Expenses across 18 years of filings, most recently posting -$12.0 million for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$12.0 million, up 77.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $170.0 million (up 431.25% YoY), and the FY2025 annual result was $129.0 million, up 292.54% from the prior year.
• Change in Accured Expenses came in at -$12.0 million for Q1 2026 at Quest Diagnostics, down from $16.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $176.0 million in Q4 2023 to a low of -$211.0 million in Q1 2023.
• The 5-year median for Change in Accured Expenses is $16.0 million (2025), against an average of -$9.1 million.
• Across the five-year window, Change in Accured Expenses soared 2100.0% in 2022 and sank 334.38% in 2023, its largest moves.
• Quest Diagnostics' Change in Accured Expenses stood at $20.0 million in 2022, then surged by 780.0% to $176.0 million in 2023, then plunged by 80.11% to $35.0 million in 2024, then plunged by 54.29% to $16.0 million in 2025, then sank by 175.0% to -$12.0 million in 2026.
• The last three Change in Accured Expenses figures came in at -$12.0 million (Q1 2026), $16.0 million (Q4 2025), and $124.0 million (Q3 2025), per Business Quant data.